Skip to main content

Brendan P. O'Grady

Board Member

Assertio Holdings, Inc.

CEO

Assertio Holdings, Inc.

Equibles does not estimate personal net worth.

About Brendan P. O'Grady

Brendan P. O'Grady is recorded as Board Member and CEO at Assertio Holdings, Inc. since May 29, 2024. Assertio Holdings, Inc. reported in an 8-K filed November 21, 2025 that Brendan P. O'Grady resigned as member of the Board of Directors, effective November 17, 2025. Assertio Holdings, Inc. reported in an 8-K filed October 30, 2025 that Brendan P. O'Grady was terminated as Chief Executive Officer, effective October 27, 2025. Assertio Holdings, Inc. reported in an 8-K filed May 29, 2024 that Brendan P. O'Grady was appointed director, effective May 29, 2024. Equibles holds 4 filed executive changes naming Brendan P. O'Grady; each is listed under recent activity with its source filing. The proxy statement of Assertio Holdings, Inc. reports total compensation of $1,884,984 for Brendan P. O'Grady in fiscal 2025, including a base salary of $721,933. Disclosed compensation is on record for 2 fiscal years. Assertio Holdings, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.

“Pursuant to and in connection with his execution of the Waiver and Release Agreement, Mr. O'Grady resigned as a member of the Board of Directors of the Company, effective as of the effective date of the Waiver and Release Agreement.”
Assertio Holdings, Inc. Form 8-K, filed November 21, 2025 · Read the filing
“Effective as of October 27, 2025, Brendan O'Grady, Chief Executive Officer and a director of Assertio Holdings, Inc. (the "Company") separated from service as Chief Executive Officer of the Company.”
Assertio Holdings, Inc. Form 8-K, filed October 30, 2025 · Read the filing

Affiliation history

  • Assertio Holdings, Inc.

    Board Member

    SEC 8-K

    Current

    2024-05-29–present

  • Assertio Holdings, Inc.

    CEO

    SEC 8-K

    Current

    2024-05-29–present

  • Assertio Holdings, Inc.

    Board Member

    Proxy statement

    2024-05-29–2025-11-17

  • Assertio Holdings, Inc.

    CEO

    SEC 8-K

    2024-05-29–2025-10-27

Company network

Assertio Holdings, Inc.

Current role

Drug Manufacturers - Specialty & Generic · Healthcare

Board Member, CEO

2024-05-29–present

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Assertio Holdings, Inc. $721,933 $1,884,984
2024 Assertio Holdings, Inc. $502,372 $3,012,703

Recent activity